ACLARION INC (ACON)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
$1.56-10.34%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
QuarterlyIQ Insights · ACON
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -75.0% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 8.4% |
Growth built into the price is above our model estimate.
The price assumes 83.4 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 9 industry peers
ACON — capital allocation — Material Modification to Rights of Security Holders
Dated 2026-03-19
Material Modification to Rights of Security Holders. On March 19, 2026, the board of directors (the “ Board ”) of Aclarion, Inc., a Delaware corporation (the “ Company ”), adopted a stockholder rights agreement and declared (i) a dividend of one right (a “ Right ”) for each outstanding share of Company common stock, par value $0.00001 per share (“ Common Stock ”), to stockholders of record at the close of business on March 30, 2026 (the “ Record Date ”) and (ii) a dividend of the aggregate nu…
Why it matters: The company linked its stock repurchase plan to continued Nociscan adoption. More use would support its growth plan.
Supportive ifOn Nov. 11, Aclarion reports more Nociscan centers or higher use than in its prior report.
Worry ifOn Nov. 11, Aclarion reports no increase in Nociscan centers or use, or reports a decline.
Why it matters: Operating losses have grown in recent quarters. A smaller loss would show progress on cost control.
Supportive ifOperating loss for the reported quarter is smaller than $2,986,941, the 2026-Q1 loss.
Worry ifOperating loss for the reported quarter is at least $2,986,941, or wider than the 2026-Q1 loss.
Why it matters: Aclarion reported $19.0 million in cash at March 31, 2026. It said that cash could fund operations through an early trial milestone.
Worry ifA later report shows cash above $19.0 million and confirms funding through the first CLARITY milestone.
Less concerning ifA later report shows cash below $19.0 million and says funds may not cover operations through that milestone.
Why it matters: The company authorized up to $2.5 million in repurchases over 12 months. Actual purchases would show how much cash it uses for this plan.
Watch forA filing or company update says the company bought back shares under the plan and states how many.
Also watch forA filing or company update says the plan paused or ended, or reports no share buybacks by April 22, 2027.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$241 on $10,000 · ±2.4% | How much price usually moves either way. |
| Bad day | $866 loss on $10,000 · 8.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $7,870 loss on $10,000 · 78.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.